-
Article
Is there any place for novel agents in treating biliary tract cancer?
Biliary tract cancer is an uncommon cancer in developed countries. In localized stages, surgery is the cornerstone of treatment with curative purpose. Conversely in advanced stages, chemotherapy with platinum–...
-
Article
Treating metastatic clear-cell renal cell carcinoma: beyond immunotherapy
First-line treatment for metastatic clear-cell renal cell carcinoma patients with intermediate and poor-risk features consists of a combination of immune checkpoint inhibitors (e.g., nivolumab + ipilimumab) or...
-
Article
A systematic review of salvage therapies in refractory metastatic colorectal cancer
Established that the only approved agents in previously treated metastatic colorectal cancer (CRC) are trifluoridine/tipiracil and regorafenib, we conducted a systematic review of all the published phase 2–3 t...